328 related articles for article (PubMed ID: 15518428)
1. [Role of the hemostatic system in pathogenesis of atherosclerosis as the main etiology of coronary ischemia] [corrected].
Lisowski P; Małyszko J; Lisowska A; Czech B; Myśliwiec M; Jackowski R; Hirnle T
Pol Merkur Lekarski; 2004 May; 16(95):465-7. PubMed ID: 15518428
[TBL] [Abstract][Full Text] [Related]
2. [Role of the hemostasis in unstable angina pectoris].
Lisowski P; Małyszko J; Lisowska A; Czech B; Myśliwiec M; Jackowski R; Hirnle T
Pol Merkur Lekarski; 2004 May; 16(95):468-71. PubMed ID: 15518429
[TBL] [Abstract][Full Text] [Related]
3. Haemostatic risk factors for cardiovascular diseases.
Koenig W
Eur Heart J; 1998 Apr; 19 Suppl C():C39-43. PubMed ID: 9597424
[TBL] [Abstract][Full Text] [Related]
4. [Hemostasis disturbances in myocardial ischemia].
Habis M; Gonzalez C; Jacq L; Pezzano M; Schaison F; Lardoux H
Ann Cardiol Angeiol (Paris); 2000 Dec; 49(8):480-7. PubMed ID: 12555436
[TBL] [Abstract][Full Text] [Related]
5. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
6. Endothelial haemostatic markers in members of families with familial combined hyperlipidemia.
Karásek D; Vaverková H; Halenka M; Slavík L; Novotný D
Thromb Res; 2009; 123(3):466-75. PubMed ID: 18417194
[TBL] [Abstract][Full Text] [Related]
7. Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study.
Smith FB; Lee AJ; Hau CM; Rumley A; Lowe GD; Fowkes FG
Blood Coagul Fibrinolysis; 2000 Jan; 11(1):43-50. PubMed ID: 10691098
[TBL] [Abstract][Full Text] [Related]
8. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
[TBL] [Abstract][Full Text] [Related]
9. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
Morange PE; Bickel C; Nicaud V; Schnabel R; Rupprecht HJ; Peetz D; Lackner KJ; Cambien F; Blankenberg S; Tiret L;
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2793-9. PubMed ID: 17023678
[TBL] [Abstract][Full Text] [Related]
10. Hemostasis and atherosclerosis.
Warkentin TE
Can J Cardiol; 1995 May; 11 Suppl C():29C-34C. PubMed ID: 7750046
[TBL] [Abstract][Full Text] [Related]
11. Relation of the prothrombotic state to increasing age (from the Framingham Offspring Study).
Tofler GH; Massaro J; Levy D; Mittleman M; Sutherland P; Lipinska I; Muller JE; D'Agostino RB
Am J Cardiol; 2005 Nov; 96(9):1280-3. PubMed ID: 16253598
[TBL] [Abstract][Full Text] [Related]
12. Haemostatic variables in Pacific Islanders apparently free from stroke and ischaemic heart disease--the Kitava Study.
Lindeberg S; Berntorp E; Carlsson R; Eliasson M; Marckmann P
Thromb Haemost; 1997 Jan; 77(1):94-8. PubMed ID: 9031456
[TBL] [Abstract][Full Text] [Related]
13. Hemostatic dysfunction associated with endocrine disorders as a major risk factor and cause of human morbidity and mortality: a comprehensive meta-review.
Mina A; Favaloro EJ; Koutts J
Semin Thromb Hemost; 2007 Nov; 33(8):798-809. PubMed ID: 18175285
[TBL] [Abstract][Full Text] [Related]
14. Increase in plasma concentration of plasminogen activator inhibitor, fibrinogen, von Willebrand factor, factor VIII:C and in erythrocyte sedimentation rate with age.
Aillaud MF; Pignol F; Alessi MC; Harle JR; Escande M; Mongin M; Juhan-Vague I
Thromb Haemost; 1986 Jun; 55(3):330-2. PubMed ID: 3092390
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein, prothrombotic imbalance and endothelial dysfunction in acute coronary syndromes without ST elevation.
Apetrei E; Ciobanu-Jurcuţ R; Rugină M; Gavrilă A; Uscătescu V
Rom J Intern Med; 2004; 42(1):95-102. PubMed ID: 15529598
[TBL] [Abstract][Full Text] [Related]
16. Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study.
Tzoulaki I; Murray GD; Price JF; Smith FB; Lee AJ; Rumley A; Lowe GD; Fowkes FG
Am J Epidemiol; 2006 Feb; 163(4):334-41. PubMed ID: 16357107
[TBL] [Abstract][Full Text] [Related]
17. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
Nowakowska A
Ann Acad Med Stetin; 2005; 51(1):95-105. PubMed ID: 16496609
[TBL] [Abstract][Full Text] [Related]
18. Endothelial dysfunction in the pathogenesis of atherosclerosis.
Poredos P
Int Angiol; 2002 Jun; 21(2):109-16. PubMed ID: 12110769
[TBL] [Abstract][Full Text] [Related]
19. Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients.
Iorio A; Federici MO; Mourvaki E; Ferolla P; Piroddi M; Stabile A; Timi A; Celleno R; Benedetti MM
Thromb Haemost; 2007 Sep; 98(3):635-41. PubMed ID: 17849053
[TBL] [Abstract][Full Text] [Related]
20. [Should hemostatic factors be considered in the prevention of cardiovascular disease?].
Musiał J; Duplaga M
Pol Tyg Lek; 1993 Aug 2-16; 48(31-33):699-702. PubMed ID: 7971494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
